← All trials
NCT01562080
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2012
- Primary completion
- Jun 1, 2012
- Completion date
- Oct 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 118
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- RottapharmLead sponsor
- University of ValenciaOverall official - principal investigator
- Universidad San JorgeOverall official - principal investigator
- Centro Tecnológico de Nutrición y SaludCollaborator
- Rovira i Virgili UniversityStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.